Skip to main content

Want a detailed portfolio tracker?

Ginkgo Bioworks (DNA) P/E (2021 - 2026)

Ginkgo Bioworks (DNA) P/E from Apr 19, 2021 to Jul 20, 2026. The TTM Ginkgo Bioworks (DNA) P/E is -1.44. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Ginkgo Bioworks (DNA)

YearP/EChange
2026-1.44-3.53%
2025-1.49+59.58%
2024-0.94-75.56%
2023-3.83+392.78%
2022-0.78-89.14%
2021-7.16N/A

Comparison Ginkgo Bioworks (DNA) P/E with competitors

Ginkgo Bioworks (DNA) P/E is -1.44.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.30%
ENLVEnlivex Ltd0.07-105.19%
FGENFibroGen Inc0.24-116.64%
CHRSCoherus Biosciences Inc0.85-158.84%
FBIOFortress Biotech Inc0.95-165.81%
ORMPOramed Pharmaceuticals Inc1.50-204.22%
AGENAgenus Inc3.01-308.69%
INVAInnoviva Inc3.15-318.70%
VXRTVaxart Inc3.55-346.14%
CRMDCorMedix Inc3.63-351.60%
CVACCureVac N.V.4.45-408.26%
GLPGGalapagos NV4.86-436.92%
SRPTSarepta Therapeutics Inc4.88-438.53%
ABEOAbeona Therapeutics Inc5.39-473.57%
ABUSArbutus Biopharma Corp5.60-488.00%
ZVRAZevra Therapeutics Inc5.89-508.22%
SPROSpero Therapeutics Inc6.23-531.88%
CGENCompugen Ltd6.31-537.81%
RIGLRigel Pharmaceuticals6.87-576.51%
SLXNSilexion Therapeutics Corp7.30-605.91%
OMEROmeros Corporation9.26-742.01%
AUPHAurinia Pharmaceuticals Inc9.58-764.63%
PLXProtalix BioTherapeutics Inc10.89-855.19%
ACADAcadia Pharmaceuticals Inc11.73-913.26%
TBPHTheravance Biopharma Inc12.26-950.26%
ADMAAdma Biologics Inc12.42-961.08%
HRMYHarmony Biosciences Holdings Inc13.82-1058.30%
SABSSAB Biotherapeutics Inc14.14-1080.21%
NAGENiagen Bioscience Inc14.82-1127.50%
INCYIncyte Corp15.82-1197.15%
REGNRegeneron Pharmaceuticals Inc15.86-1199.51%
PBYIPuma Biotechnology Inc17.32-1300.68%
CPRXCatalyst Pharmaceuticals Inc17.44-1309.25%
EXELExelixis Inc17.54-1316.10%
TGTXTG Therapeutics Inc18.97-1415.12%
MDXGMimedx Group Inc20.55-1525.13%
XOMAXOMA Royalty Corp22.87-1686.19%
ARGXArgen X SE24.30-1784.89%
CTMXCytomX Therapeutics Inc24.82-1821.16%
XOMAOXOMA Royalty Corp25.34-1857.47%
HALOHalozyme Therapeutics Inc25.62-1876.81%
XOMAPXOMA Royalty Corp25.67-1880.03%
VRTXVertex Pharmaceuticals Inc27.99-2041.23%
RPRXRoyalty Pharma plc - Class A28.69-2089.27%
SLNOSoleno Therapeutics Inc29.02-2112.00%
ASNDAscendis Pharma A/S30.09-2186.21%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2728.92%
APLSApellis Pharmaceuticals Inc39.02-2805.83%
BMRNBiomarin Pharmaceutical Inc42.21-3027.08%
KRYSKrystal Biotech Inc45.34-3244.23%
ONCBeiGene Ltd69.54-4922.11%
PHARPharming Group N.V.75.03-5302.47%
TECHBio-Techne Corp101.96-7170.06%
VCELVericel Corp109.92-7722.23%
ALNYAlnylam Pharmaceuticals Inc117.96-8280.01%
GMABGenmab140.29-9828.13%
TLXTelix Pharmaceuticals Ltd162.15-11344.10%
CORTCorcept Therapeutics Inc212.86-14860.09%